Clinical Trial Update: To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the efficacy and safety of batoclimab in adults with active Chronic Inflammatory Demyelinating Polyneuropathy; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Batoclimab (batoclimab)

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Chronic Inflammatory Demyelinating Polyneuropathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING